Controversial rocket scientist in India threatens legal action after journals pull papers

A professor of aerospace engineering in India who developed a scientific theory critics call “absolute nonsense” said he is suing journal editors and publishers for pulling three papers he claims could help protect “millions of lives.”

The articles, one in Springer Nature’s Scientific Reports and two in Wiley’s Global Challenges, described a highly technical concept eponymously dubbed “Sanal flow choking.” The first was retracted last summer, the other two in March.

“The retractions of our papers are unjustified,” V. R. Sanal Kumar of Amity University in New Delhi told Retraction Watch. “Our legal representatives are actively pursuing a defamation lawsuit against these editors and their illicit agents who were responsible for retracting articles crucial for safeguarding countless lives.” 

He and his team “are in the process of filing the petition,” Kumar added. 

Disgruntled authors have sued publishers over retractions in the past, as we reported in 2021, but have not been successful

According to Kumar and his coauthors, their work is “a scientific breakthrough and a paradigm shift” that could help solve “numerous unresolved scientific problems in physical, chemical and biological sciences.” The many claimed applications include cardiovascular and neurological diseases. 

But the research has met hefty criticism from peers.

“The elementary blunders are so obvious that someone who reads their works for at least 10-15 mins should realise that all of it is absolute nonsense,” Ganesh Natarajan, of the department of mechanical engineering at the Indian Institute of Technology Palakkad, told Retraction Watch by email.

Natarajan, who alerted Wiley to his concerns about Kumar’s publications in May 2022, added: 

The theory of flow of gases through rocket motors simply does not apply to blood flow through human arteries – Sanal and his co-workers completely ignore this aspect citing similarity of geometries between rocket nozzles and stenosed arteries. From here, they blatantly make baseless conclusions on how the ‘Sanal flow choking’ can explain asymptomatic cardiovascular disease, myocardial infarction, neurological disorders, Moyamoya disease and Spontaneous Coronary Artery Dissection (SCAD) – all of which makes absolutely no sense.

The identical retraction notices in Global Challenges, published March 25, 2024, state: 

Post-publication review by an independent reviewer determined that the article applies the concept of compressible flow to an inherently incompressible flow system. As a result, the article’s hypothesis and following argument do not scientifically support its conclusions. Therefore, the conclusions are considered unreliable.

An investigation by Wiley and the journal’s Editor-in-Chief supported this conclusion.

The June 6, 2023, retraction notice in Scientific Reports offered more details: 

Following publication, concerns were raised about the rationale for the approach presented, the assumptions and approximations used and the validity of its application to cardiology. A post-publication review of the Authors’ mathematical arguments revealed a lack of clarity in the terms presented and inferences that are not adequately justified. The main concerns are that the model is based on circular reasoning which makes it non-predictive, that it assumes that blood behaves as an ideal gas, and hypothesizes that quasi-sonic flow velocities exist in the cardiovascular system while all experimental evidence shows that cardiovascular flow velocities are orders of magnitude lower than the speed of sound and do not involve any compressibility effects. The Editors therefore no longer have confidence in the conclusions presented.

Kumar stood by his work, telling us:

It is important to clarify that the retractions and criticisms directed towards our work do not reflect scientific inaccuracies or flaws in the concept of Sanal flow choking. Rather, they appear to be part of a coordinated effort to discredit our research through what I believe to be an international conspiracy.

He added:

Having thoroughly examined the criticisms referenced, including the links to PubPeer and the arXiv article, I maintain that our research methodology is sound and has undergone rigorous peer review.

Furthermore, connected research papers are currently under review by flagship journals.

Kumar also forwarded correspondence with Wiley in which he told the publisher his retracted papers were “instrumental in safeguarding millions of lives.”

Natarajan questioned the quality of the original peer review of Kumar’s papers, but welcomed the results of the post-publication reviews. What is “more worrying,” he said, is that two influential physics journals from AIP Publishing – AIP Advances and Physics of Fluids – “haven’t really bothered to consider the matter despite raising complaints.” 

We contacted the editors of these journals and heard back from Wendy Beatty, director of content experience at AIP Publishing:

In light of the retractions in other journals, we will review both your requests and the related material and comments.

Kumar grabbed headlines in India last May after the country’s Supreme Court upheld his dismissal years earlier from the national space agency. According to The Economic Times, the court said Kumar’s former employer “was justified in suspecting his honesty and integrity on account of his unauthorised association with a South Korean institution involved in rocketry research.”

Kumar unsuccessfully challenged the decision and, according to a screenshot he shared with Retraction Watch, in February of this year filed a “curative petition” – a legal last resort – with the court. 

In his papers, Kumar continues to claim the Vikram Sarabhai Space Centre (VSSC) of the Indian Space Research Organisation (ISRO) as his primary affiliation. He told us:

Ongoing legal challenges against ISRO’s actions persist in the Hon’ble Supreme Court of India, and should a favorable verdict be delivered, I will be reinstated with retroactive service benefits. Consequently, I will continue to assert my VSSC affiliation in my publications pending the final judgment of the Supreme Court of India.

Natarajan said Kumar’s petition doesn’t stand a chance: “His belief in this case is akin to his belief in his works – and sadly both end up being flawed with him on the wrong side of the situation.”

Like Retraction Watch? You can make a tax-deductible contribution to support our work, subscribe to our free daily digest or paid weekly updatefollow us on Twitter, like us on Facebook, or add us to your RSS reader. If you find a retraction that’s not in The Retraction Watch Database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

Exclusive: Wiley journal editor under investigation for duplicate publications

Daniel Joseph Berdida

An academic editor at Wiley who vowed to “uphold publication ethics” is being investigated by the company for allegedly publishing three of his papers twice, in violation of journal policies, Retraction Watch has learned.

One of the duplicates, which appeared last year in Nurse Education in Practice, an Elsevier title, has already been slated for retraction, according to emails we have seen. The other offending articles were published in Wiley journals.

The editor, Daniel Joseph Berdida, is a nurse and faculty member at the University of Santo Tomas in Manila, the Philippines. He joined the editorial board of Wiley’s Journal of Nursing Management four months ago, announcing on LinkedIn that he would “be serving with integrity and uphold publication ethics.”

After being confronted about the duplicate publication by Roger Watson, editor-in-chief of Nurse Education in Practice, Berdida acknowledged his transgression, explaining he had been “on health leave” for the past eight months and “a breakdown in communication” with his research assistant had “led to the current situation.”

“I fully acknowledge my responsibility in this matter,” Berdida wrote in a March 13 email. “If it is within your discretion, I would appreciate it if you could consider retracting the manuscript from your journal, given the circumstances.”

But Berdida had made the same excuse to one of the Wiley journals, and Watson was unconvinced. 

“As with all violations of publication ethics, this is a most unfortunate set of duplications,” he told us. “It is doubly unfortunate for the author that the editors-in-chief of three of the publications involved are very close colleagues and regularly consult one another for advice. In this way we were able to tie the three incidences of duplication together. Let’s hope there are no more.”

The three duplicate articles are:

On March 20, Watson wrote to Berdida:

This is to inform you that Elsevier will be retracting your article in Nurse Education in Practice and due to the fact that we are aware of further duplications in other journals we are not satisfied with your response. Under these circumstances we consider that it is necessary to inform your dean.

Mark Hayter, editor-in-chief of the Journal of Clinical Nursing, in which one of the duplicate papers appeared, confirmed his publication was “involved in this matter,” adding, “It is currently being investigated by the Wiley publication ethics team.”

Berdida has not responded to our request for comment. The dean of his university’s College of Nursing, Rowena L. Escolar Chua, declined to comment, explaining, “I do not know the full story and the matter is still being investigated.”

Like Retraction Watch? You can make a tax-deductible contribution to support our work, subscribe to our free daily digest or paid weekly updatefollow us on Twitter, like us on Facebook, or add us to your RSS reader. If you find a retraction that’s not in The Retraction Watch Database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

Iran COVID-vaccine paper with ‘serious flaws’ retracted

via Wikimedia

Following criticism from scientists around the world, a virology journal has retracted a paper describing the first test in humans of an Iran-made vaccine against COVID-19.

Iran licensed the home-grown Noora vaccine for emergency use in 2022 and has reportedly administered millions of doses to its citizens. The country’s health authorities say the shot is 94% effective

The now-retracted paper, published in 2022 in the Journal of Medical Virology, was the only report on the clinical development of the vaccine to have appeared in an international journal. The article has been cited 10 times, according to Clarivate’s Web of Science.

In a commentary last year in the same journal, Donald Forthal, chief of infectious diseases at the University of California, Irvine, raised several concerns about the article, titled “Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial.” 

As we reported in October, Forthal questioned the efficacy of the vaccine and expressed surprise “a manuscript containing so many serious flaws would have been accepted for publication following peer review, and given these issues, a retraction may be in order.” 

The journal’s editor-in-chief, Shou-Jiang Gao, said at the time the paper had undergone two rounds of “rigorously [sic] review by experts of the field” before it was published. The authors had responded to Forthal’s critique, Gao told us, and their response had “already undergone 3 rounds of review, each with 2 reviewers”:

The last decision was made on October 24, 2023 and deadline for submitting the revision is November 23, 2023. So, we are waiting for the authors to submit the last revision before accepting and publishing it. This should fully address the issues that are raised.  

But the response was never published. Meanwhile, in January, Gideon Meyerowitz-Katz, an epidemiologist in Australia, flagged additional problems in the paper on PubPeer, including several “impossible” and “contradictory” numbers. 

On March 2, the journal announced the paper had been retracted, stating:

The retraction has been agreed due to concerns raised by third parties regarding issues with the data presented in the article. Several inconsistencies concerning the information provided about the analyzed subjects were additionally identified. Furthermore, the authors failed to disclose the presence of potential conflicts of interest that may have affected the interpretation of the results presented. Accordingly, the editors consider the conclusions of this manuscript to be invalid. The authors have been informed of the decision to retract but did not agree with it.

Corresponding author Hassan Abolghasemi of Baqiyatallah University of Medical Sciences, in Tehran, told us by email:

Retraction of our article was a political decision not a scientific decision because there was a pressure on journal based on [apartheid] scientific issue. Our response to the comment never accepted by [PubPeer] and journal to be published.

Two days after the retraction, another group of researchers published a study in mice comparing the effect of four COVID-19 vaccines used in Iran.

“Our results indicate significant immunogenicity and neutralization efficacy induced by PastoCovac Plus and Sinopharm, but not by Noora and SpikoGen,” the team wrote in the article, which cited the now-retracted paper. “This suggests the need for additional comparative assessment of the potency and efficacy of these four vaccines in vaccinated subjects.”

Like Retraction Watch? You can make a tax-deductible contribution to support our work, subscribe to our free daily digest or paid weekly updatefollow us on Twitter, like us on Facebook, or add us to your RSS reader. If you find a retraction that’s not in The Retraction Watch Database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

Exclusive: Physician in India who coauthored review with US profs is running a paper mill

A recent review article whose authors included two assistant professors at universities in the United States was written by a physician in India who is running a paper mill, Retraction Watch has learned.

Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics” appeared last year in a special issue of Biosensors, an MDPI title. The article came to our attention because it matched an ad posted by the Indian paper mill iTrilon, as we reported earlier this year;  some of the author names appeared on other iTrilon publications as well. 

The two assistant professors – Yuguang Liu of Mayo Clinic in Rochester, Minn., and Ajeet Kaushik of Florida Polytechnic University in Lakeland – have not previously been tied to paper-mill publications and denied any knowledge of the ad.

According to MDPI, the link between the review and iTrilon was too weak to warrant investigation – a stance the publisher has since revised. New evidence we obtained and shared with MDPI shows the paper’s first author, Shreya Singh Beniwal, is no stranger to the seedy haunts of scholarly publishing. (Beniwal lists her affiliation as Lady Hardinge Medical College, in Delhi, on her papers, although her LinkedIn page states she left the school in 2021.)

As evidenced by a video shared with us by an anonymous tipster, Beniwal manages a sprawling network of groups and communities on the messaging platform WhatsApp. There, she and a colleague peddle author slots on research papers for between $50 and $500 each.

On Dec. 18, 2023, for instance, Beniwal posted an ad for “Paper 301” to one of her WhatsApp communities – “Research Projects: Review Articles, systematic Review And Meta-analysis Community 1” –  promising acceptance in a Scopus-indexed journal within a month. 

Authorship of the article, which was titled “Assessment of effects on cardiovascular system in systemic hepatocellular carcinoma therapy: A meta analysis,” came with a price tag of 38,000 Indian rupees (about $460) for the first position, dropping to 29,000 Indian rupees ($350) for the tenth.

The paper mill operation seems tied to a murky, fee-based membership organization called The Global Achievers Research Academy (GARA), which is also managed, at least in part, by Beniwal. 

According to a document shown in the video, members get access to support and training related to research, networking and scientific writing. Some apparently are eligible for an upgrade with extra perks. In an announcement posted to her WhatsApp community “Research Ambassadors,” Beniwal congratulated “Our Ambassadors Who Have Reached Team Milestones!” and invited them to join the community where the ad for “Paper 301” appeared.

Beniwal, who goes by the username “Dr.” on the messaging app, also welcomed the “research ambassadors” to a network called “ExquisiteGARA: The Gateway to Advanced Research and Analysis.” Participation came with such benefits as “designations like ‘Senior Ambassador’ or ‘Coordinator’” and “free participation and potential authorship for recruiting new members.” 

She proceeded to list “Our Recent Publications,” which counted the Biosensors review and an earlier paper of hers that precisely matched an iTrilon ad and has since been quietly withdrawn, as we reported in January.

In a notice posted later to the community where the ad for “Paper 301” appeared, Beniwal explained that “Participants at ExquisiteGARA” would need to pay two separate fees: a non-refundable “participation fee” as well as publication charges to be “equally shared among all members involved in the project.” 

“As we embark on various exciting research projects at ExquisiteGARA, it is crucial for all participating members to clearly understand the financial aspects associated with these projects,” the notice stated.  

Beniwal deactivated the community featuring the “Paper 301” ad in January, shortly before the publication of a six-month Retraction Watch investigation in Science that focused on how iTrilon and other paper mills had infiltrated journals across the globe. But she and a colleague with the WhatsApp handle “Education” continue the authorship trade elsewhere on the platform.

In WhatsApp and email exchanges with Retraction Watch, Beniwal denied selling authorship. “And there was not any selling regarding my [Biosensors review] paper. All authors worked ethically and we have worked on it for months. There must be some misunderstanding regarding it,” she told us.

She said of her and her coauthors: 

We connected with each other with the help of LinkedIn and WhatsApp groups with friends and colleague’s [sic] help and connections…… also I have got connections with corresponding author in the same way. Most of the paper was written by me including few figures and initial 5 sections and remaining task was handled by corresponding author by adding other members….. as they also contributed in writing some parts and final revisions were done after that depending upon revision related comments by journal. 

ExquisiteGARA, Beniwal added, is not a “platform to sell the papers. That is for workshops.” In the video we received “the good things are hidden and are being misinterpreted.” 

Asked about her affiliation with Lady Hardinge Medical College, Beniwal dodged the question and responded angrily, “Why I am even talking to you here. I am not answerable to your silly questions.”

A representative of MDPI told us on behalf of Biosensors’ editorial office:

Thank you for providing us with further details. We have also conducted a comprehensive investigation internally via our Research Integrity department. As a result, we have identified and confirmed Dr. Shreya Singh Beniwal involvement in certain unethical activities and situations related to paper mills and authorship selling activities. The published article is presently under investigation as well, and in terms of future actions, we will keep adhering to COPE guidelines and recommendations. Each submission will be meticulously evaluated on a case-by-case basis, employing standard checks and screening procedures. We will maintain high level of vigilance, particularly when dealing with suspicious activities associated with paper mills that have been previously identified through online records. We will engage in thorough discussions with the journal’s Editor-in-Chief and members of the Editorial Board to address this matter effectively.

Like Retraction Watch? You can make a tax-deductible contribution to support our work, subscribe to our free daily digest or paid weekly updatefollow us on Twitter, like us on Facebook, or add us to your RSS reader. If you find a retraction that’s not in The Retraction Watch Database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

Exclusive: Elsevier to retract paper by economist who failed to disclose data tinkering

Almas Heshmati

A paper on green innovation that drew sharp rebuke for using questionable and undisclosed methods to replace missing data will be retracted, its publisher told Retraction Watch.

Previous work by one of the authors, a professor of economics in Sweden, is also facing scrutiny, according to another publisher. 

As we reported earlier this month, Almas Heshmati of Jönköping University mended a dataset full of gaps by liberally applying Excel’s autofill function and copying data between countries – operations other experts described as “horrendous” and “beyond concern.”

Heshmati and his coauthor, Mike Tsionas, a professor of economics at Lancaster University in the UK who died recently, made no mention of missing data or how they dealt with them in their 2023 article, “Green innovations and patents in OECD countries.” Instead, the paper gave the impression of a complete dataset. One economist argued in a guest post on our site that there was “no justification” for such lack of disclosure.

Elsevier, in whose Journal of Cleaner Production the study appeared, moved quickly on the new information. A spokesperson for the publisher told us yesterday: “We have investigated the paper and can confirm that it will be retracted.”

We first contacted Heshmati after a PhD student tipped us off about his dubious research practices. The student had obtained Heshmati’s dataset, which, along with email correspondence between the professor and the student, revealed how Heshmati had approached the numerous missing observations in the data. 

When we presented Heshmati with the criticism leveled against him, the researcher stood by his methods, but said they should have been “acknowledged and explained.” He had missed doing so “unintentionally in the writing stage of the paper,” he said.

It’s a mistake Heshmati has made twice, it turns out. In 2020, he and two colleagues published a paper in Empirical Economics, a Springer Nature title, that bore strong resemblance to the 2023 article and relied on the same patched-up dataset. The article mentioned neither the data gaps nor the Excel operations.

The 2020 paper, “Green innovations and patenting renewable energy technologies,” has been cited 23 times, according to Clarivate’s Web of Science.

A spokesperson for Springer Nature told us:

Thank you for bringing these concerns to our attention. We are now looking into the matter carefully following an established procedure and in line with best-practice COPE guidance. We would be happy to provide an update when we have completed our investigation.

When we reached out to Heshmati about the 2020 paper, he told us he used the same data as in the later article, but with some “differences in the way the variables are defined and transformed.” As such, he said, the description of the data was similar between the two papers:

The first paper is cited in the second paper. Journal of Cleaner Production has strict control of similarity rate and decline [sic] papers with high rate of similarity regardless of their authors.

Heshmati also said he was “disappointed” by Retraction Watch’s “approach and clearly implied false accusations”:

As you well know, I was open to supporting [the PhD student who contacted Heshmati], after exchanging some e-mail [I] sent him a zoom link and had a long zoom meeting with him explaining the reason of imputation of missing observations and their benefits and harms. I shared the data with him where all imputed points are highlighted in yellow color to allow future replacement. I have been all the way open, honest, and willing to share information without fear of negative publicity. I still believe that I did right and would use the technique again on same data but with deleting years and countries with high frequency of missing values and produce sensitivity analysis of the result with full and restricted sample.

Esfandiar Maasoumi, a professor of economics at Emory University in Atlanta and first author of the 2020 paper, said he believed Heshmati to be “honest and reliable,” but denied involvement in and knowledge of the data imputation. He told Retraction Watch:

I take data accuracy and transparency very seriously. I did not have any hand in data and code/implementation parts of the paper, and relied on my coauthors for these components. I regard my coauthor, Dr. Heshmati, as very honest and reliable and well informed. I would reject any implication that he has intentionally done anything improper.

Maasoumi also characterized Retraction Watch’s coverage of Heshmati’s research as “sensational” and “rather uninformed” and said we jumped to conclusions about intentions:

The criticism of lack of reporting should be placed on both authors and journals that do not allow or accommodate full descriptions of work in scarce journal pages. I noted that Dr. Heshmati had willingly, and openly engaged with [the PhD student who approached Heshmati about the missing data] and completely cooperated with him/her. This is clear indication of his good and honest intentions. Personally, my experience with other authors for the last 50 years is that it is next to impossible to get data, code, and meaningful correspondence with authors of papers, published or otherwise.

He elaborated, quoting experts we spoke with:

Any reader of your work here, and generally, would note that the central, key message, is ” dishonesty”, or ” cheating” as you put it and imply it very strongly. Given that those implications are categorically false, will you write a retraction, a correction, and contact the same sources immediately?

Heshmati did hand over his data to the PhD student, if grudgingly.

“I have the excel data file but do not distribute it as I may update and use it again in research,” Heshmati wrote in an email seen by Retraction Watch. “Now I have teaching and a busy schedule, but if your intension [sic] is to learn I may show you the file.”

The student vowed not to share the spreadsheet with others – a promise he later broke after realizing just how appalling Heshmati’s methods were. So much of the data had been filled in by Heshmati it felt to the student like “fabrication” warranting a retraction.

Like Retraction Watch? You can make a tax-deductible contribution to support our work, subscribe to our free daily digest or paid weekly updatefollow us on Twitter, like us on Facebook, or add us to your RSS reader. If you find a retraction that’s not in The Retraction Watch Database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

Indian paper mill disbands WhatsApp community following investigation

An Indian paper mill featuring prominently in our recent investigation in Science and a companion piece on our website shut down its WhatsApp community six days after the stories ran, Retraction Watch has learned.

The company, called iTrilon, used the messaging platform to hawk authorship of “readymade” publications to scientists “struggling to write and publish papers in PubMed and Scopus-Indexed Journals.” It claimed to have connections at journals that allowed the mill to guarantee acceptance of most of its papers.

But on January 24, Sarath Ranganathan, iTrilon’s scientific director, deactivated the WhatsApp community he had been curating.

“That’s big,” said Siddhesh Zadey, a PhD student at Columbia University and co-founder of the India-based think tank ASAR, who joined the iTrilon community last year and was a key source for our investigation. “I think it took [Ranganathan] about two years to build such a large group on WhatsApp.”

According to an infographic from last May, the Chennai-based company at the time had published “219+ papers” for clients in “21+” countries. The size of its WhatsApp community is not clear, but it likely exceeded 1,024, the maximum number of members in a WhatsApp “group.” In the platform’s terminology, a “community” is a collection of “groups.” 

The company has also taken down its website and LinkedIn profiles.

Ranganathan did not answer calls to his WhatsApp number.

Like Retraction Watch? You can make a tax-deductible contribution to support our work, subscribe to our free daily digest or paid weekly updatefollow us on Twitter, like us on Facebook, or add us to your RSS reader. If you find a retraction that’s not in The Retraction Watch Database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

No data? No problem! Undisclosed tinkering in Excel behind economics paper

Almas Heshmati

Last year, a new study on green innovations and patents in 27 countries left one reader slack-jawed. The findings were no surprise. What was baffling was how the authors, two professors of economics in Europe, had pulled off the research in the first place. 

The reader, a PhD student in economics, was working with the same data described in the paper. He knew they were riddled with holes – sometimes big ones: For several countries, observations for some of the variables the study tracked were completely absent. The authors made no mention of how they dealt with this problem. On the contrary, they wrote they had “balanced panel data,” which in economic parlance means a dataset with no gaps.

“I was dumbstruck for a week,” said the student, who requested anonymity for fear of harming his career. (His identity is known to Retraction Watch.)

The student wrote a polite email to the paper’s first author, Almas Heshmati, a professor of economics at Jönköping University in Sweden, asking how he dealt with the missing data. 

In email correspondence seen by Retraction Watch and a follow-up Zoom call, Heshmati told the student he had used Excel’s autofill function to mend the data. He had marked anywhere from two to four observations before or after the missing values and dragged the selected cells down or up, depending on the case. The program then filled in the blanks. If the new numbers turned negative, Heshmati replaced them with the last positive value Excel had spit out. 

The student was shocked. Replacing missing observations with substitute values – an operation known in statistics as imputation – is a common but controversial technique in economics that allows certain types of analyses to be carried out on incomplete data. Researchers have established methods for the practice; each comes with its own drawbacks that affect how the results are interpreted. As far as the student knew, Excel’s autofill function was not among these methods, especially not when applied in a haphazard way without clear justification.

But it got worse. Heshmati’s data, which the student convinced him to share, showed that in several instances where there were no observations to use for the autofill operation, the professor had taken the values from an adjacent country in the spreadsheet. New Zealand’s data had been copied from the Netherlands, for example, and the United States’ data from the United Kingdom. 

This way, Heshmati had filled in thousands of empty cells in the dataset – well over one in 10 – including missing values for the study’s outcome variables. A table listing descriptive statistics for the study’s 25 variables referred to “783 observations” of each variable, but did not mention that many of these “observations” were in fact imputations.

“This fellow, he imputed everything,” the student said. “He is a professor, he should know that if you do so much imputation then your data will be entirely fabricated.”

Other experts echoed the student’s concerns when told of the Excel operations underlying the paper.

“That sounds rather horrendous,” said Andrew Harvey, a professor of econometrics at the University of Cambridge, in England. “If you fill in lots of data points in this way it will invalidate a lot of the statistics and associated tests. There are ways of dealing with these problems correctly but they do require some effort.

“Interpolating data is bad practice but lots of people do it and it’s not dishonest so long as it’s mentioned,” Harvey added. “The other point about copying data from one country to another sounds much worse.”

Søren Johansen, an econometrician and professor emeritus at the University of Copenhagen, in Denmark, characterized what Heshmati did as “cheating.” 

“The reason it’s cheating isn’t that he’s done it, but that he hasn’t written it down,” Johansen said. “It’s pretty egregious.” 

The paper, “Green innovations and patents in OECD countries,” was published in the Journal of Cleaner Production, a highly ranked title from Elsevier. It has been cited just once, according to Clarivate’s Web of Science.

Neither the publisher nor the journal’s editors, whom the student said he alerted to his concerns, have responded to our requests for comment.

Heshmati’s coauthor, Mike Tsionas, a professor of economics at Lancaster University in the UK, died recently. In a eulogy posted on LinkedIn in January, the International Finance and Banking Society hailed Tsionas as “a true luminary in the field of econometrics.” 

In a series of emails to Retraction Watch, Heshmati, who, according to the paper, was responsible for data curation, first said Tsionas had been aware of how Heshmati dealt with the missing data.

“If we do not use imputation, such data is almost useless,” Heshmati said. He added that the description of the data in the paper as “balanced” referred to “the final data” – that is, the mended dataset.

Referring to the imputation, Heshmati wrote in a subsequent email:

Of course, the procedure must be acknowledged and explained. I have missed to explain the imputation procedure in the data section unintentionally in the writing stage of the paper. I am fully responsible for imputations and missing to acknowledge it.

He added that when he was approached by the PhD student: 

I offered him a zoom meeting to explain to him the procedure and even gave him the data. If I had other intensions [sic] and did not believe in my imputation approach, I would not share the data with him. If I had to start over again, I would have managed the data in the same way as the alternative would mean dropping several countries and years.

Gary Smith, a professor of economics at Pomona College in Claremont, California, said the copying of data between countries was “beyond concerning.” He reviewed Heshmati’s spreadsheet for Retraction Watch and found five cases where more than two dozen data points had been copied from one country to another. 

Marco Hafner, a senior economist at the RAND Corporation, a nonprofit think tank, said “using the autofill function may not be the best of ideas in the first place as I can imagine it is not directly evident to what conditions missing values have been determined/imputed.”

Hafner, who is research leader at RAND Europe, added that “under reasonable assumptions and if it’s really necessary for analytical reasons, one could fill in data gaps for one country with data from another country.” But, he said, the impact of those assumptions would need to be reported in a sensitivity analysis – something Heshmati said he had not done. 

“At the bare minimum,” Hafner said, the paper should have stated the assumptions underlying the imputation and how it was done – something that, he added, would have reduced the chances of the work getting published should the reviewers find the methods inappropriate.

Like Retraction Watch? You can make a tax-deductible contribution to support our work, subscribe to our free daily digest or paid weekly updatefollow us on Twitter, like us on Facebook, or add us to your RSS reader. If you find a retraction that’s not in The Retraction Watch Database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

Journal pulls papers following Retraction Watch investigation

A journal quietly retracted two papers after a six-month Retraction Watch investigation linked them, and two of the journal’s editors, to the Indian paper mill iTrilon.

Based in Chennai, iTrilon hawks authorship of “readymade” publications to scientists “struggling to write and publish papers in PubMed and Scopus-Indexed Journals.” The company, whose website disappeared following our exposé in Science, claims to have connections at journals that allow it to guarantee acceptance of many of its papers. 

The two retracted papers – “Evaluation of the neuroprotective activity of citral nanoemulsion on Alzheimer’s disease-type dementia in a preclinical model: The assessment of cognitive and neurobiochemical responses” and “Therapeutic effects of quercetin-loaded phytosome nanoparticles in a preclinical model of Parkinson’s disease: The modulation by antioxidant pathways and BDNF expression” – had both been put up for sale by iTrilon before they appeared last year in the non-indexed journal Life Neuroscience

We published the matching ads last week in a companion piece to the Science article that linked a professor and dean at a university in Spain to several iTrilon papers. The dean, Dionisio Lorenzo Lorenzo Villegas of Universidad Fernando Pessoa-Canarias, in Las Palmas, acknowledged paying the paper mill, but said he thought the money was meant to cover article-processing charges. He has since taken down his LinkedIn profile.

The editor-in-chief of Life Neuroscience, Nasrollah Moradikor of the International Center for Neuroscience Research, in Tbilisi, Georgia, confirmed the journal had pulled Lorenzo’s two papers, although it has not issued retraction notices.

“Today, I asked our managing editor and told them about Dionisio Lorenzo Lorenzo Villegas, his article retracted from our journal website [sic],” Moradikor wrote in a January 22 email to Retraction Watch.

But as we reported in Science, Moradikor was the corresponding author of the paper about Alzheimer’s disease, which was touted by iTrilon after being accepted by the journal and just two weeks before publication. As such, he should have known about author additions.

According to a WhatsApp exchange about the paper, iTrilon’s scientific director, Sarath Ranganathan, described it as “a collaborative research carried out at Georgia [sic]. Authors from any country are allowed.” 

Moradikor, who stopped answering emails in October after we told him we were interested in discussing “your work as an editor and your connection with iTrilon,” now denies any links with the paper mill.

“I’m shocked, that you mentioned me and Dr. Indranath Chatterjee [a coauthor on the Alzheimer’s paper] on this News,” he wrote in his email. “We don’t have any relation with Itrilon and Dionisio Lorenzo Lorenzo Villegas in Spain.”

But last autumn, Chatterjee gave a talk on scientific publishing organized by iTrilon and the International Center for Neuroscience Research, as we reported in Science. And in an October interview, Chatterjee, who is also an editor at Life Neuroscience, said Lorenzo had been involved in the work for the Alzheimer’s paper “mostly like for the supervising and also kind of reviewing and like checking the paper and the manuscript are properly written or not.” 

Asked how he had met Lorenzo, Chatterjee said, “Actually, like, you know, it was in connection with the International Center for Neuroscience, not with me.”

Like Retraction Watch? You can make a tax-deductible contribution to support our work, subscribe to our free daily digest or paid weekly updatefollow us on Twitter, like us on Facebook, or add us to your RSS reader. If you find a retraction that’s not in The Retraction Watch Database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

Posted by in Uncategorized

Permalink

Exclusive: Mayo, Florida profs among authors of article tied to Indian paper mill

Yuguang Liu

Two assistant professors at universities in the United States are coauthors of a review that appears to have been advertised for sale by the Indian paper mill iTrilon, a Retraction Watch investigation has found.

One of the professors, Yuguang Liu of Mayo Clinic in Rochester, Minn., is also guest editor of the MDPI special issue in the journal Biosensors in which the review was published last year. The other professor, Ajeet Kaushik of Florida Polytechnic University, in Lakeland, sits on the editorial boards of Biosensors and several other titles from MDPI, Elsevier, Wiley, Springer Nature and other publishers.

An MDPI representative said Liu, who declined an interview request, had not been involved in editorial decisions regarding the paper. Meanwhile, Kaushik acknowledged his work on the article had sprung from a LinkedIn message from a researcher in India who, as we reported last week, has been offering co-authorship in return for help getting his articles published.

“This is sad,” Kaushik told us by email, adding that he had not seen “any red flags” when he agreed to collaborate on the review. 

Ajeet Kaushik

“I contributed to this review article as an ethical co-author,” he said. “I am making it clear that my role in this article does not have any involvement of money or other exchange offers.”

The paper’s link to iTrilon became apparent during a six-month Retraction Watch investigation for Science that found paper mills had taken to bribing journal editors to ensure publication of their articles. Based in Chennai, iTrilon sells authorship of “readymade” scientific papers and gets them published through a network of editors with whom it claims to be working. The company’s website was taken down following our story.

As we reported in a companion piece to the Science article, papers advertised last year by iTrilon buoyed the research output of Dionisio Lorenzo Lorenzo Villegas, a professor and dean at Universidad Fernando Pessoa-Canarias, in Las Palmas, Spain. Lorenzo acknowledged paying the company.

The review in Biosensors is one of the six papers Lorenzo coauthored in 2023 that could be linked to iTrilon. The matching ad was posted in July and referred to a “review article” about “diagnostics for colorectal cancer,” to be submitted to a journal “indexed in PubMed, Scopus and Web of Science” with an impact factor above 3. 

These details are all consistent with the review, “Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics,” which was submitted to Biosensors on August 29.

But Giulia Stefenelli, chair of the scientific board of MDPI, said the publisher was not investigating the paper. 

“It is important to note that establishing a direct link between the articles and the content advertised by the cited platform is not an easy process. The titles of the articles and the number of authors do not immediately correlate with the published material. Should we receive further evidence that clearly distinguishes the relationship to the publications unequivocally, we will proceed to initiate an official investigation,” Stefenelli told Retraction Watch.

Liu, who is a corresponding author of the review, did not agree to an interview. But she said in an email that she was “unaware” of the iTrilon ad matching the paper and that “I don’t think it’s related to my paper or the special issue on MDPI.”

We were unable to find contact information for the review’s first author, Shreya Singh Beniwal of Lady Hardinge Medical College, in New Delhi. Beniwal was also first author of a research article coauthored by Lorenzo, which unequivocally matched a previous ad from iTrilon and has now been retracted. 

How the authors came to collaborate on the review is only partly clear. A LinkedIn message from last spring reveals ArunSundar MohanaSundaram, an assistant professor at Sathyabama Institute of Science and Technology, in Chennai, and co-corresponding author of the review, had been proffering author slots on manuscripts to researchers who could help get them published. 

“I’m ready to offer ‘co authorship’ if you could review the work and support me as an EDITOR in reputed journals,” MohanaSundaram, who has coauthored several papers advertised for sale by iTrilon, wrote in the message, as we reported last week. He did not respond to repeated emails.

MohanaSundaram, Lorenzo and Beniwal came up with the idea for the review article, according to the statement on author contributions.

Kaushik said he had not heard of iTrilon until we reached out to him. But he acknowledged being contacted by MohanaSundaram:

Yes, I was approached by Dr. Arun on LinkedIn but at the beginning of this REVIEW ARTICLE. Then this paper moved forward by email exchanges. The similarity Index was acceptable, and all figures were either self-designed or with the permission. So, I did not see any red flags. I was involved in this article due to my credentials in the field of biosensors and nanomedicine.

Kaushik added:

Please note, that I am a young scholar and working hard to make a good name based on clean and ethical research. I generally want to help, but such incidents are centaily aletrs, and I will be more careful and reserv in the future [sic]. 

Presently, I am seeing some of the approaches (so-called shortcuts) to get easy or sponsored publications. BUT, I do not like and support such approaches.

Both Mayo Clinic and MDPI emphasized that Liu had not been involved in editorial decisions regarding the manuscript.

“The paper’s scientific review, revision, and submission process was handled by an Assistant Editor, Mila Opacic, not Dr. Liu,” Andrea Kalmanovitz, director of Communications – Media Relations at Mayo Clinic, said in an email. She did not reply to follow-up questions about how Liu had come into contact with far-flung authors linked to paper-mill articles.

According to Stefenelli at MDPI:

The article was accepted by the Section editor-in-chief of “Nano- and Micro-Technologies in Biosensors,” to which the Special issue belongs, Prof. Michael Thompson. In accordance with MDPI editorial procedure, Guest Editors are completely excluded from the peer-review process and decision-making stages for articles submitted by themselves and their colleagues. The MDPI procedure seeks for an independent assessment by a member of the Editorial Board for all cases of conflict of interest (https://www.mdpi.com/ethics#_bookmark17).

Kaushik, who is a member of the editorial board for the same section of the journal, said he had not been involved in any editorial decisions regarding the review article, nor in the selection of the journal.

Like Retraction Watch? You can make a tax-deductible contribution to support our work, subscribe to our free daily digest or paid weekly updatefollow us on Twitter, like us on Facebook, or add us to your RSS reader. If you find a retraction that’s not in The Retraction Watch Database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.

Wiley reopens plagiarism case about dead researcher’s work

Zulfiqar Habib, dean of computer science at COMSATS University Islamabad, in Pakistan, was appalled when he discovered part of a former PhD student’s dissertation had been published in a scientific journal.

After all, the former student, Kurshid Asghar, had been dead for more than a year by the time the manuscript was submitted to Security and Communication Networks, a Hindawi title. And Habib knew none of Asghar’s coauthors had contributed to the research, which Habib had supervised. 

“It was both shocking and unbelievable,” he told Retraction Watch.

Habib decided to share his concerns with Roberto Di Pietro, chief editor of Security and Communication Networks, in which the paper had appeared in September 2021. What followed was a strange and opaque investigation, which Wiley, Hindawi’s parent company, now says had “some limitations” and is being revisited following Retraction Watch’s inquiry.

In a December 2021 email to Di Pietro, Habib wrote:

May I have your attention on a very serious issue about academic fraud. A group of people has illegally published a research paper in your esteemed journal by stealing a chapter of PhD thesis … This paper is copied from Chapter 6 of PhD Thesis of Dr. Khurshid Asghar after his death without the consent and knowledge of his PhD supervisor (Dr. Zulfiqar Habib) and co-supervisor (Dr. Muhammad Hussain).

A research integrity specialist at Hindawi wrote back to inform Habib that, according to the authors, Asghar had shared his work with them:

And while Dr Asghar wrote the original draft, they contributed to the article by editing this original draft with Dr Asghar prior to submission and then answering the reviewers comments.

The authors were willing to add Habib to the author list, the Hindawi specialist said. But Habib demurred. Instead, he asked to see “documentary evidence” proving the authors weren’t just trying to “hide academic fraud and justify plagiarism.” 

In subsequent emails, the specialist told Habib the authors had submitted documentation for their claims but Habib couldn’t see it:

… as you are not conducting an official investigation into this allegation of research misconduct, we cannot share the evidence provided by the authors with you without the consent of all parties. We cannot obtain Dr Asghar’s consent and he is a party within the documentation provided.

Di Pietro chimed in to note that he found Zulfiqar’s point of view “quite reasonable” and suggested starting “an appropriate level of investigation.” 

But in June 2022, Hindawi shut down the case. As the research integrity specialist wrote in an email to Habib:

We have received notification that you have contacted COMSATS University Islamabad to request a formal investigation into the authorship of the article:

Muhammad Hameed Siddiqi, Khurshed Asghar, Umar Draz, Amjad Ali, Madallah Alruwaili, Yousef Alhwaiti, Saad Alanazi, M. M. Kamruzzaman, “Image Splicing-Based Forgery Detection Using Discrete Wavelet Transform and Edge Weighted Local Binary Patterns”, Security and Communication Networks, vol. 2021, Article ID 4270776, 10 pages, 2021. https://doi.org/10.1155/2021/4270776

We have received the report from the committee formed to investigate this issue in which it was found that the article by Siddiqi et al. did not plagiarise other works. Given the outcome of the investigation, we are now closing this complaint.

COMSATS University Islamabad did not reply to requests for comment. Nor did Muhammad Hameed Siddiqi, the paper’s first author, nor Umar Draz, its corresponding author. 

But in an email, a spokesperson for Wiley told us:

We are aware of some limitations with the initial investigation and have re-opened the case. We will be reaching out to the parties involved to outline next steps and to ensure that an appropriate outcome is reached as promptly as possible.

They later added:

We revisited the case as a result of this inquiry, and have decided to reopen it.

Like Retraction Watch? You can make a tax-deductible contribution to support our work, subscribe to our free daily digest or paid weekly updatefollow us on Twitter, like us on Facebook, or add us to your RSS reader. If you find a retraction that’s not in The Retraction Watch Database, you can let us know here. For comments or feedback, email us at team@retractionwatch.com.